BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 12566076)

  • 1. Use of the A(2A) adenosine receptor as a physiological immunosuppressor and to engineer inflammation in vivo.
    Sitkovsky MV
    Biochem Pharmacol; 2003 Feb; 65(4):493-501. PubMed ID: 12566076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting G protein-coupled A2a adenosine receptors to engineer inflammation in vivo.
    Gomez G; Sitkovsky MV
    Int J Biochem Cell Biol; 2003 Apr; 35(4):410-4. PubMed ID: 12565702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting hypoxia--A(2A) adenosine receptor-mediated mechanisms of tissue protection.
    Lukashev D; Ohta A; Sitkovsky M
    Drug Discov Today; 2004 May; 9(9):403-9. PubMed ID: 15081957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory cytokines regulate function and expression of adenosine A(2A) receptors in human monocytic THP-1 cells.
    Khoa ND; Montesinos MC; Reiss AB; Delano D; Awadallah N; Cronstein BN
    J Immunol; 2001 Oct; 167(7):4026-32. PubMed ID: 11564822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible targeting of G protein coupled receptors to manipulate inflammation in vivo using synthetic and natural ligands.
    Kinsel JF; Sitkovsky MV
    Ann Rheum Dis; 2003 Nov; 62 Suppl 2(Suppl 2):ii22-4. PubMed ID: 14532142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling.
    Nishi A; Liu F; Matsuyama S; Hamada M; Higashi H; Nairn AC; Greengard P
    Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1322-7. PubMed ID: 12538871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage.
    Ohta A; Sitkovsky M
    Nature; 2001 Dec 20-27; 414(6866):916-20. PubMed ID: 11780065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes.
    Link AA; Kino T; Worth JA; McGuire JL; Crane ML; Chrousos GP; Wilder RL; Elenkov IJ
    J Immunol; 2000 Jan; 164(1):436-42. PubMed ID: 10605040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A(2A) receptor agonists and endotoxin.
    Leibovich SJ; Chen JF; Pinhal-Enfield G; Belem PC; Elson G; Rosania A; Ramanathan M; Montesinos C; Jacobson M; Schwarzschild MA; Fink JS; Cronstein B
    Am J Pathol; 2002 Jun; 160(6):2231-44. PubMed ID: 12057925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine receptors and inflammation.
    Blackburn MR; Vance CO; Morschl E; Wilson CN
    Handb Exp Pharmacol; 2009; (193):215-69. PubMed ID: 19639284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human D2 dopamine receptor synergizes with the A2A adenosine receptor to stimulate adenylyl cyclase in PC12 cells.
    Kudlacek O; Just H; Korkhov VM; Vartian N; Klinger M; Pankevych H; Yang Q; Nanoff C; Freissmuth M; Boehm S
    Neuropsychopharmacology; 2003 Jul; 28(7):1317-27. PubMed ID: 12784121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A2A receptors in inflammation and injury: lessons learned from transgenic animals.
    Haskó G; Pacher P
    J Leukoc Biol; 2008 Mar; 83(3):447-55. PubMed ID: 18160539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Removal of the carboxy terminus of the A2A-adenosine receptor blunts constitutive activity: differential effect on cAMP accumulation and MAP kinase stimulation.
    Klinger M; Kuhn M; Just H; Stefan E; Palmer T; Freissmuth M; Nanoff C
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Oct; 366(4):287-98. PubMed ID: 12237741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th1 cytokines regulate adenosine receptors and their downstream signaling elements in human microvascular endothelial cells.
    Nguyen DK; Montesinos MC; Williams AJ; Kelly M; Cronstein BN
    J Immunol; 2003 Oct; 171(8):3991-8. PubMed ID: 14530318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of the cyclic AMP response to forskolin in pheochromocytoma PC12 cells through adenosine A(2A) purinoceptors.
    Florio C; Frausin F; Vertua R; Gaion RM
    J Pharmacol Exp Ther; 1999 Aug; 290(2):817-24. PubMed ID: 10411597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine attenuates oxidant injury in human proximal tubular cells via A(1) and A(2a) adenosine receptors.
    Lee HT; Emala CW
    Am J Physiol Renal Physiol; 2002 May; 282(5):F844-52. PubMed ID: 11934694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine receptor targeting in health and disease.
    Gessi S; Merighi S; Fazzi D; Stefanelli A; Varani K; Borea PA
    Expert Opin Investig Drugs; 2011 Dec; 20(12):1591-609. PubMed ID: 22017198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine is upregulated during peritonitis and is involved in downregulation of inflammation.
    Rogachev B; Ziv NY; Mazar J; Nakav S; Chaimovitz C; Zlotnik M; Douvdevani A
    Kidney Int; 2006 Aug; 70(4):675-81. PubMed ID: 16788688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors.
    Pinhal-Enfield G; Ramanathan M; Hasko G; Vogel SN; Salzman AL; Boons GJ; Leibovich SJ
    Am J Pathol; 2003 Aug; 163(2):711-21. PubMed ID: 12875990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors.
    Kull B; Arslan G; Nilsson C; Owman C; Lorenzen A; Schwabe U; Fredholm BB
    Biochem Pharmacol; 1999 Jan; 57(1):65-75. PubMed ID: 9920286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.